Viewing Study NCT01441804


Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2025-12-30 @ 8:21 PM
Study NCT ID: NCT01441804
Status: UNKNOWN
Last Update Posted: 2013-10-01
First Post: 2011-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module